查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
顱內治療藥輸送的全球市場的分析:由於神經疾病的盛行率上升和對再生醫療的轉移而受惠的產業
市場調查報告書
商品編碼
1129603

顱內治療藥輸送的全球市場的分析:由於神經疾病的盛行率上升和對再生醫療的轉移而受惠的產業

Market Study on Intracranial Therapeutic Delivery: Industry Benefiting from Rising Neurological Disorder Prevalence and Tangible Shift toward Regenerative Medicines
出版日期: | 出版商: Persistence Market Research | 英文 168 Pages | 商品交期: 2-5個工作天內

價格

本報告提供全球顱內治療藥輸送的市場相關分析，技術概要和市場結構，主要的推動及阻礙市場要素，市場規模、成長率的變化與預測 (2022年～2032年)，各治療、各適應症及各地區、主要國家詳細趨勢，目前市場競爭狀態，主要企業簡介等調查。

目錄

第1章 摘要整理

第2章 市場概要

第3章 主要市場趨勢

  • 左右市場的主要趨勢
  • 產品革新/開發趨勢

第4章 主要成功因素

  • 疾病的流行病學
  • 主要的推銷策略: 各製造廠商
  • 波特分析
  • 大環境分析
  • 價值鏈

第5章 市場背景情況

  • 宏觀經濟要素
    • 全球GDP成長率預測
    • 全球醫療費
  • 預測要素:相關性及影響度
    • 大企業的過去的成長
    • GDP的成長預測
    • 企業間的策略性合作
    • 遺傳基因為基礎的治療用開發中產品增加
    • 神經疾病的盛行率增加
    • 新興企業的市場進入
  • 市場動態
    • 促進因素
    • 阻礙因素

第6章 新型冠狀病毒感染疾病 (COVID-19) 危機的分析

  • 市場設想情境 (2021年)
  • COVID-19及影響分析
    • 收益:各治療
    • 收益:各適應症
    • 收益:各國

第7章 全球顱內治療藥輸送市場:需求的分析與預測 (以金額為準)

  • 過去的市場與分析
  • 現在、未來市場與預測
    • 與前一年同期比較成長率 (YoY) 趨勢分析

第8章 全球顱內治療藥輸送市場分析與預測:各治療

  • 簡介/主要調查結果
  • 過去的市場規模的分析:各治療
  • 現在、未來市場規模的分析與預測:各治療
    • 細胞療法
    • 基因治療
    • 酵素補充療法
  • 市場魅力分析:各治療

第9章 全球顱內治療藥輸送市場分析與預測:各適應症

  • 簡介/主要調查結果
  • 過去的市場規模的分析:適應症
  • 現在、未來市場規模的分析與預測:各適應症
    • 脊髓性肌萎縮症 (SMA)
    • 多發性硬化症
    • 巴頓病
    • 肌肉萎縮性脊髓側索硬化症
  • 市場魅力分析:各適應症

第10章 全球顱內治療藥輸送市場分析與預測:各地區

  • 簡介/主要調查結果
  • 過去的市場規模的分析:各地區
  • 現在、未來市場規模的分析與預測:各地區
    • 美國
    • 歐洲
    • 其他的國家 (RoW)
  • 市場魅力分析:各地區

第11章 美國的顱內治療藥輸送市場分析與預測

  • 簡介
  • 過去的市場規模的分析:各市場區隔
  • 現在、未來市場預測:各市場區隔
    • 各治療
    • 各適應症
  • 市場魅力分析
  • 主要打入市場企業:競爭密度製圖
  • 推動及阻礙市場要素:影響度的分析

第12章 歐洲的顱內治療藥輸送市場分析與預測

  • 簡介
  • 過去的市場規模的分析:各市場區隔
  • 現在、未來市場預測:各市場區隔
    • 各國
    • 各治療
    • 各適應症
  • 市場魅力分析
  • 主要打入市場企業:競爭密度製圖
  • 推動及阻礙市場要素:影響度的分析
  • 國家等級的分析與預測
    • 德國的顱內治療藥輸送市場
    • 法國的顱內治療藥輸送市場
    • 義大利的顱內治療藥輸送市場
    • 西班牙的顱內治療藥輸送市場
    • 英國的顱內治療藥輸送市場
    • 荷比盧三國的顱內治療藥輸送市場
    • 北歐各國的顱內治療藥輸送市場
    • 俄羅斯的顱內治療藥輸送市場

第13章 其他的國家 (RoW) 的顱內治療藥輸送市場分析與預測

  • 簡介
  • 過去的市場規模的分析:各市場區隔
  • 現在、未來市場預測:各市場區隔
    • 各治療
    • 各適應症
  • 市場魅力分析
  • 主要打入市場企業:競爭密度製圖
  • 推動及阻礙市場要素:影響度的分析

第14章 市場結構分析

  • 市場分析:企業的各等級
  • 主要企業的市場佔有率分析
  • 市場影響分析
    • 企業的各地區足跡
    • 產品足跡:各企業
    • 流通管道的足跡:各企業

第15章 競爭分析

  • 競爭儀表板
  • 競爭的基準
  • 競爭詳細內容(一時性清單)
    • Novartis AG
    • BioMarin
    • CORESTEM Inc.
    • Alaunos Therapeutics, Inc.
    • Apic Bio
    • Stemedica Cell Technologies, Inc.
    • Voyager Therapeutics
    • Bayer AG
    • Abeona Therapeutics
    • Spark Therapeutics

第16章 所使用的前提條件與縮寫

第17章 調查手法

Product Code: PMRREP33142

Scope of the Report:

The latest publication by Persistence Market Research on the global intracranial therapeutic delivery market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Researchs study. This research study can support readers to know the demand for intracranial therapeutic delivery therapies and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the intracranial therapeutic delivery market. Insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the intracranial therapeutic delivery market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the intracranial therapeutic delivery market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments:

Persistence Market Research's study on the intracranial therapeutic delivery market offers information divided into three important segments - therapy, indication, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Therapy

  • Cell Therapy
  • Gene Therapy
  • Enzyme Replacement Therapy

Indication

  • Microbial Cell Culture
  • Mammalian Cell Culture
  • Plant Tissue Culture
  • Yeast Culture

Region

  • U.S.
  • Europe
  • ROW

Key Questions Answered:

  • Which regions will continue to remain the most profitable markets for intracranial therapeutic delivery over the coming years?
  • How will changing trends impact market growth?
  • How has the COVID-19 crisis impacted market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the strategies of stakeholders in the market to shape their position in this landscape?
  • What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends that will impact the market?
  • How can companies in the intracranial therapeutic delivery market avail themselves of the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the intracranial therapeutic delivery market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the intracranial therapeutic delivery market more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions / Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Disease Epidemiology
  • 4.2. Key Promotional Strategies, By Manufacturers
  • 4.3. Porter's Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Value Chain

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Companies Historical Growth
    • 5.2.2. GDP Growth forecast
    • 5.2.3. Strategic Collaborations among Players
    • 5.2.4. Rising Number of Pipeline Products for Gene-Based Therapies
    • 5.2.5. Growing prevalence of Neurologic Diseases
    • 5.2.6. Entries of new start-up companies in the market
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. 2021 Market Scenario
  • 6.2. COVID-19 and Impact Analysis
    • 6.2.1. Revenue by Therapy
    • 6.2.2. Revenue by Indication
    • 6.2.3. Revenue by Country

7. Global Intracranial Therapeutic Delivery Market Demand (in Value or Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022-2032, By Therapy

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Trend Analysis By Therapy, 2017-2021
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Therapy, 2022-2032
    • 8.3.1. Cell-Based Therapy
    • 8.3.2. Gene Therapy
    • 8.3.3. Enzyme Replacement Therapy
  • 8.4. Market Attractiveness Analysis By Therapy

9. Global Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022-2032, by Indication

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2017-2021
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2022-2032
    • 9.3.1. Spinal Muscular Atrophy (SMA)
    • 9.3.2. Multiple Sclerosis
    • 9.3.3. Batten Disease
    • 9.3.4. Amyotrophic lateral sclerosis
  • 9.4. Market Attractiveness Analysis By Indication

10. Global Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022-2032, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Trend Analysis, By Region, 2017-2021
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2032
    • 10.3.1. U.S.
    • 10.3.2. Europe
    • 10.3.3. Rest of the World (ROW)
  • 10.4. Market Attractiveness Analysis By Region

11. U.S Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022-2032

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032
    • 11.3.1. By Therapy
    • 11.3.2. By Indication
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Therapy
    • 11.4.2. By Indication
  • 11.5. Key Market Participants - Intensity Mapping
  • 11.6. Drivers and Restraints - Impact Analysis

12. Europe Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022-2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032
    • 12.3.1. By Country
      • 12.3.1.1. Germany
      • 12.3.1.2. Italy
      • 12.3.1.3. France
      • 12.3.1.4. U.K.
      • 12.3.1.5. Spain
      • 12.3.1.6. BENELUX
      • 12.3.1.7. Nordic Countries
      • 12.3.1.8. Russia
      • 12.3.1.9. Rest of Europe
    • 12.3.2. By Therapy
    • 12.3.3. By Indication
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Therapy
    • 12.4.3. By Indication
  • 12.5. Key Market Participants - Intensity Mapping
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Country Level Analysis & Forecast
    • 12.7.1. Germany Intracranial Therapeutic Delivery Market
      • 12.7.1.1. Introduction
      • 12.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.7.1.2.1. By Therapy
        • 12.7.1.2.2. By Indication
    • 12.7.2. France Intracranial Therapeutic Delivery Market
      • 12.7.2.1. Introduction
      • 12.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.7.2.2.1. By Therapy
        • 12.7.2.2.2. By Indication
    • 12.7.3. Italy Intracranial Therapeutic Delivery Market
      • 12.7.3.1. Introduction
      • 12.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 12.7.3.2.1. By Therapy
        • 12.7.3.2.2. By Indication
    • 12.7.4. Spain Intracranial Therapeutic Delivery Market
      • 12.7.4.1. Introduction
      • 12.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 12.7.4.2.1. By Therapy
        • 12.7.4.2.2. By Indication
    • 12.7.5. U.K. Intracranial Therapeutic Delivery Market
      • 12.7.5.1. Introduction
      • 12.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 12.7.5.2.1. By Therapy
        • 12.7.5.2.2. By Indication
    • 12.7.6. Benelux Union Intracranial Therapeutic Delivery Market
      • 12.7.6.1. Introduction
      • 12.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 12.7.6.2.1. By Therapy
        • 12.7.6.2.2. By Indication
    • 12.7.7. Nordic Countries Intracranial Therapeutic Delivery Market
      • 12.7.7.1. Introduction
      • 12.7.7.2. Market Analysis and Forecast by Market Taxonomy
        • 12.7.7.2.1. By Therapy
        • 12.7.7.2.2. By Indication
    • 12.7.8. Russia Intracranial Therapeutic Delivery Market
      • 12.7.8.1. Introduction
      • 12.7.8.2. Market Analysis and Forecast by Market Taxonomy
        • 12.7.8.2.1. By Therapy
        • 12.7.8.2.2. By Indication

13. Rest of the World (ROW) Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022-2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032
    • 13.3.1. By Therapy
    • 13.3.2. By Indication
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Therapy
    • 13.4.2. By Indication
  • 13.5. Key Market Participants - Intensity Mapping
  • 13.6. Drivers and Restraints - Impact Analysis

14. Market Structure Analysis

  • 14.1. Market Analysis by Tier of Companies
  • 14.2. Market Share Analysis of Top Players
  • 14.3. Market Presence Analysis
    • 14.3.1. By Regional footprint of Players
    • 14.3.2. Product footprint by Players
    • 14.3.3. Channel Foot Print by Players

15. Competition Analysis

  • 15.1. Competition Dashboard
  • 15.2. Competition Benchmarking
  • 15.3. Competition Deep Dive [Tentative list]
    • 15.3.1. Novartis AG
      • 15.3.1.1. Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Key Financials
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Sales Footprint
      • 15.3.1.6. Strategy Overview
      • 15.3.1.7. Key Developments
    • 15.3.2. BioMarin
      • 15.3.2.1. Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Key Financials
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Sales Footprint
      • 15.3.2.6. Strategy Overview
      • 15.3.2.7. Key Developments
    • 15.3.3. CORESTEM Inc.
      • 15.3.3.1. Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Key Financials
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Sales Footprint
      • 15.3.3.6. Strategy Overview
      • 15.3.3.7. Key Developments
    • 15.3.4. Alaunos Therapeutics, Inc.
      • 15.3.4.1. Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Key Financials
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Sales Footprint
      • 15.3.4.6. Strategy Overview
      • 15.3.4.7. Key Developments
    • 15.3.5. Apic Bio
      • 15.3.5.1. Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Key Financials
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Sales Footprint
      • 15.3.5.6. Strategy Overview
      • 15.3.5.7. Key Developments
    • 15.3.6. Stemedica Cell Technologies, Inc.
      • 15.3.6.1. Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Key Financials
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Sales Footprint
      • 15.3.6.6. Strategy Overview
      • 15.3.6.7. Key Developments
    • 15.3.7. Voyager Therapeutics
      • 15.3.7.1. Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Key Financials
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Sales Footprint
      • 15.3.7.6. Strategy Overview
      • 15.3.7.7. Key Developments
    • 15.3.8. Bayer AG
      • 15.3.8.1. Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Key Financials
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Sales Footprint
      • 15.3.8.6. Strategy Overview
      • 15.3.8.7. Key Developments
    • 15.3.9. Abeona Therapeutics
      • 15.3.9.1. Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Key Financials
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Sales Footprint
      • 15.3.9.6. Strategy Overview
      • 15.3.9.7. Key Developments
    • 15.3.10. Spark Therapeutics
      • 15.3.10.1. Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Key Financials
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Sales Footprint
      • 15.3.10.6. Strategy Overview
      • 15.3.10.7. Key Developments

16. Assumptions and Acronyms Used

17. Research Methodology

List of Tables

  • Table 01: U.S. & Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Therapy
  • Table 02: U.S. & Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Indication
  • Table 03: U.S. & Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Region
  • Table 04: U.S. Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Therapy
  • Table 05: U.S. Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Indication
  • Table 06: Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Therapy
  • Table 07: Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Indication
  • Table 08: Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
  • Table 09: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Therapy
  • Table 10: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Indication

List of Figures

  • Figure 01: Global Intracranial Therapeutic Delivery Market Value Analysis (US$ Mn), 2017-2021
  • Figure 02: Global Intracranial Therapeutic Delivery Market Value Forecast (US$ Mn), 2022-2032
  • Figure 03: Global Intracranial Therapeutic Delivery Market Absolute $ Opportunity, 2022-2032
  • Figure 04: Global Intracranial Therapeutic Delivery Market Share Analysis (%), By Therapy, 2022 & 2032
  • Figure 05: Global Intracranial Therapeutic Delivery Market Attractiveness Analysis By Therapy, 2022-2032
  • Figure 06: Global Intracranial Therapeutic Delivery Market Share Analysis (%), By Indication, 2022 & 2032
  • Figure 07: Global Intracranial Therapeutic Delivery Market Attractiveness Analysis By Indication, 2022-2032
  • Figure 08: Global Intracranial Therapeutic Delivery Market Share Analysis (%), By Region, 2022 & 2032
  • Figure 09: U.S. Intracranial Therapeutic Delivery Market Share By Therapy 2022 (E)
  • Figure 10: U.S. Intracranial Therapeutic Delivery Market Share By Indication 2022 (E)
  • Figure 11: U.S Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F
  • Figure 12: U.S Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F
  • Figure 13: U.S. Intracranial Therapeutic Delivery Market Value Analysis (US$ Mn), 2017-2021
  • Figure 14: U.S. Intracranial Therapeutic Delivery Market Value Forecast (US$ Mn), 2022-2032
  • Figure 15: U.S. Intracranial Therapeutic Delivery Market Attractiveness Analysis By Therapy, 2022-2032
  • Figure 16: U.S. Intracranial Therapeutic Delivery Market Attractiveness Analysis By Indication, 2022-2032
  • Figure 17: Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F
  • Figure 18: Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F
  • Figure 19: Europe Intracranial Therapeutic Delivery Market Share By Therapy 2022 (E)
  • Figure 20: Europe Intracranial Therapeutic Delivery Market Share By Indication 2022 (E)
  • Figure 21: Europe Intracranial Therapeutic Delivery Market Share By Country 2022 (E)
  • Figure 22: Europe Intracranial Therapeutic Delivery Market Value Analysis (US$ Mn), 2017-2021
  • Figure 23: Europe Intracranial Therapeutic Delivery Market Value Forecast (US$ Mn), 2022-2032
  • Figure 24: Europe Intracranial Therapeutic Delivery Market Attractiveness Analysis By Therapy, 2022-2032
  • Figure 25: Europe Intracranial Therapeutic Delivery Market Attractiveness Analysis By Indication, 2022-2032
  • Figure 26: Europe Intracranial Therapeutic Delivery Market Attractiveness Analysis By Country, 2022-2032
  • Figure 27: Germany Market Value Proportion Analysis, 2021
  • Figure 28: Germany Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032
  • Figure 29: Germany Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032
  • Figure 30: Italy Market Value Proportion Analysis, 2021
  • Figure 31: Italy Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032
  • Figure 32: Italy Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032
  • Figure 33: Spain Market Value Proportion Analysis, 2021
  • Figure 34: Spain Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032
  • Figure 35: Spain Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032
  • Figure 36: France Market Value Proportion Analysis, 2021
  • Figure 37: France Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032
  • Figure 38: France Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032
  • Figure 39: U.K. Market Value Proportion Analysis, 2021
  • Figure 40: U.K. Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032
  • Figure 41: U.K. Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032
  • Figure 42: BENELUX Market Value Proportion Analysis, 2021
  • Figure 43: BENELUX Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032
  • Figure 44: BENELUX Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032
  • Figure 45: Nordic Countries Market Value Proportion Analysis, 2021
  • Figure 46: Nordic Countries Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032
  • Figure 47: Nordic Countries Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032
  • Figure 48: Russia Market Value Proportion Analysis, 2021
  • Figure 49: Russia Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032
  • Figure 50: Russia Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032
  • Figure 51: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F
  • Figure 52: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F
  • Figure 53: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Share By Therapy 2022 (E)
  • Figure 54: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Share By Indication 2022 (E)
  • Figure 55: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Value Analysis (US$ Mn), 2017-2021
  • Figure 56: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Value Forecast (US$ Mn), 2022-2032
  • Figure 57: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Attractiveness Analysis By Therapy, 2022-2032
  • Figure 58: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Attractiveness Analysis By Indication, 2022-2032